Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-05 | Amended | $12,609,962 | $5,929,970 | Equity Only | 06b | SEC link |
| 2022-09-30 | New | $6,679,992 | $6,679,992 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jonathan Fleming | Director |
| Wyatt Gotbetter | Director |
| Stephen R. Seiler | Director, Executive |
| Ids Van Der Weij | Director |